Being female puts you at risk of developing osteoporosis and broken bones. Here are some facts: Of the estimated 10 million Americans with osteoporosis, about eight million or 80% are women. Approximately one in two women over age 50 will break a bone because of osteoporosis. A woman’s risk of breaking a hip is equal… Read more »
Search Results for: calcium
Frequently Asked Questions
Nutrition and Supplements Exercise Risk Factors Medications General
Preventing Falls
Each year about one-third of all people over age 65 will fall. Many of these falls result in broken bones. Some common causes of falls include outdoor and indoor hazards. Certain lifestyle behaviors can also increase your chances of falling. Outdoor Safety Tips Try the following tips to help prevent falls when you are outside:… Read more »
BHOF Events
Included below is a list of events happening across the country that may be of interest to osteoporosis patients, their family, caregivers, healthcare providers and/or the general public. Upcoming Events Past Events & Recordings How To Exercise Safely With Bone Loss This 1-hour webinar includes NOF online community volunteer moderator, Susie Hathaway speaking about exercising… Read more »
New Wall Street Journal Article on the Benefits of Bisphosphonates Outweighing the Risks for Many Patients
The Wall Street Journal recently published an article detailing the benefits of bisphosphonates outweighing the risks for many patients. Text from the full article is included below. View the original article with graphics and visuals. More Support for Osteoporosis Drugs: The benefits of bisphosphonates outweigh the risks for many patients, according to new research and… Read more »
Teriparatide Parathyroid Hormone (PTH) (1-34) (BonsityĀ® and ForteoĀ®)
Teriparatide, a type of parathyroid hormone, is approved for the treatment of osteoporosis in postmenopausal women and in men who are at high risk of breaking a bone. It is also approved for the treatment of osteoporosis in men and women who are at high risk of breaking a bone as a result of taking… Read more »
Denosumab (Prolia)
Denosumab is approved by the FDA for the treatment of osteoporosis in postmenopausal women at high risk of fracture and to increase bone mass in men with osteoporosis at high risk of fracture. The medicine is also approved to increase bone mass in men receiving androgen deprivation therapy for prostate cancer who are at high… Read more »
Calcitonin-Salmon (ForticalĀ® and MiacalcinĀ®)
Calcitonin is a synthetic hormone for the treatment of osteoporosis in postmenopausal women who are at least five years beyond menopause when other medicines are not suitable. The naturally occurring hormone is involved in calcium regulation and bone metabolism. Calcitonin slows bone breakdown and increases bone density in the spine. It reduces the risk of… Read more »
Side Effects of Bisphosphonates (Alendronate, Ibandronate, Risedronate and Zoledronic Acid)
Side effects for all the bisphosphonates (alendronate, ibandronate, risedronate and zoledronic acid) may include bone, joint or muscle pain. Side effects of the oral tablets may include nausea, difficulty swallowing, heartburn, irritation of the esophagus (tube connecting the throat to the stomach) and gastric ulcer. When low levels of calcium in the blood are present,… Read more »
Risedronate Sodium (ActonelĀ®, AtelviaTM)
Risedronate (Actonel) is approved for the prevention and treatment of osteoporosis in postmenopausal women and for the treatment of osteoporosis in men. It also is approved for the prevention and treatment of glucocorticoid-induced osteoporosis in men and women as a result of long-term use of steroid medicines (examples are prednisone and cortisone). Risedronate (Atelvia) is… Read more »